Sofinnova Ventures »

Alcon shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Alcon (ALC) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Alcon

Tip: Access up to 7 years of quarterly data

All positions including Alcon held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alcon by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2025-12-31 $26M 333k 78.81

More positions owned by Sofinnova Ventures

Natera (NTRA)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Astrazeneca Sponsored Adr
Vera Therapeutics Cl A (VERA)
Bristol Myers Squibb (BMY)
United Therapeutics Corporation (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbvie (ABBV)
Intuitive Surgical (ISRG)
Cogent Biosciences (COGT)
Eli Lilly & Co. (LLY)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Avidity Biosciences Ord (RNA)
Dyne Therapeutics (DYN)

View all positions for Sofinnova Ventures

Top funds holding Alcon

Vanguard Group
UBS Group
Bank of New York Mellon
Norges Bank Investment Management
FMR
Reed Conner & Birdwell
Zurcher Kantonalbank
Ako Capital
Select Equity
Goldman Sachs Group
Amundi
Deutsche Bank Aktiengesellschaft
Franklin Resources
Pictet Asset Management Holding SA
Harding Loevner

View all funds holding Alcon